Difference between revisions of "Medulloblastoma"
Jump to navigation
Jump to search
Jensflorian (talk | contribs) (→Subtypes: prognosis) |
Jensflorian (talk | contribs) (→Subtypes: SHH subgroups) |
||
Line 68: | Line 68: | ||
==Subtypes== | ==Subtypes== | ||
===Histologically defined=== | |||
*Classic medulloblastoma (~85% of all medulloblastomas). | *Classic medulloblastoma (~85% of all medulloblastomas). | ||
*Variants of medulloblastoma (~15% of all medulloblastomas together): | *Variants of medulloblastoma (~15% of all medulloblastomas together): | ||
Line 73: | Line 75: | ||
*#Desmoplastic/nodular medulloblastoma (DNMB). | *#Desmoplastic/nodular medulloblastoma (DNMB). | ||
*#Medulloblastoma with extensive nodularity (MBEN). | *#Medulloblastoma with extensive nodularity (MBEN). | ||
====Anaplastic variant==== | ====Anaplastic variant==== | ||
Line 81: | Line 82: | ||
*Polygonal cells. | *Polygonal cells. | ||
===Genetically defined=== | |||
*WNT | |||
*SHH | |||
**infantile and adult cases are biologically different, esp p53 mutant tumors are associated with poor outcome.<ref>{{Cite journal | last1 = Kool | first1 = M. | last2 = Jones | first2 = DT. | last3 = Jäger | first3 = N. | last4 = Northcott | first4 = PA. | last5 = Pugh | first5 = TJ. | last6 = Hovestadt | first6 = V. | last7 = Piro | first7 = RM. | last8 = Esparza | first8 = LA. | last9 = Markant | first9 = SL. | title = Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. | journal = Cancer Cell | volume = 25 | issue = 3 | pages = 393-405 | month = Mar | year = 2014 | doi = 10.1016/j.ccr.2014.02.004 | PMID = 24651015 }}</ref> | |||
*Group 3 | |||
*Group 4 | |||
==Prognosis== | ==Prognosis== |
Revision as of 14:26, 21 September 2017
Medulloblastoma is a malignant small round cell tumour that is found in the cerebellum.
Morphologically identical supratentorial tumours are called primitive neuroectodermal tumour (PNET).
General
- Mostly paediatric population.
- May be seen as a component of nevoid basal cell carcinoma syndrome (NBCCS).
- Gene: patched (abbreviated PTCH1).[1]
- Commonly spread via cerebrospinal fluid (CSF).[2]
- May be detected in CSF cytopathology specimens.
Gross
- Location: cerebellum - key feature.
- Morphologically identical supratentorial tumours are called primitive neuroectodermal tumour (PNET).
- Supratentorial and spinal metastases from initial tumor possible.
Microscopic
Features:[3]
- Small round cell tumour.
- Homer-Wright rosettes:
- Rosette with a meshwork of fibers (neuropil) at the centre.[4]
IHC
- MAP2 usu. +ve
- Synaptophysin +ve (weak to strong)
- NSE +ve/-ve
- NF +ve/-ve
- Chromogranin +ve/-ve
- GFAP +ve/-ve (mostly along blood vessels)
- Vimentin +ve
- Nestin +ve
- INI1 retained (no loss)
DDx:
Images
Case:
Partial MAP2 immunoreactivity. (WC/jensflorian)
www:
- Medulloblastoma (ouhsc.edu).
- Medulloblastoma - several images (upmc.edu).
- Medulloblastoma with rhabdomyoblastic differentiation - several images (upmc.edu).
Subtypes
Histologically defined
- Classic medulloblastoma (~85% of all medulloblastomas).
- Variants of medulloblastoma (~15% of all medulloblastomas together):
- Anaplastic / Large cell variant.
- Desmoplastic/nodular medulloblastoma (DNMB).
- Medulloblastoma with extensive nodularity (MBEN).
Anaplastic variant
Features:
- Larger cells.
- Severe anaplasia.
- Polygonal cells.
Genetically defined
- WNT
- SHH
- infantile and adult cases are biologically different, esp p53 mutant tumors are associated with poor outcome.[5]
- Group 3
- Group 4
Prognosis
- Prognosis based on histology:[6][7][8] DNMB & MBEN > classic > anaplastic variant, large cell variant.
See also
References
- ↑ Online 'Mendelian Inheritance in Man' (OMIM) 601309
- ↑ Lefkowitch, Jay H. (2006). Anatomic Pathology Board Review (1st ed.). Saunders. pp. 424 Q34. ISBN 978-1416025887.
- ↑ URL: http://moon.ouhsc.edu/kfung/jty1/neurotest/Q93-Ans.htm. Accessed on: 26 October 2010.
- ↑ Wippold FJ, Perry A (March 2006). "Neuropathology for the neuroradiologist: rosettes and pseudorosettes". AJNR Am J Neuroradiol 27 (3): 488–92. PMID 16551982.
- ↑ Kool, M.; Jones, DT.; Jäger, N.; Northcott, PA.; Pugh, TJ.; Hovestadt, V.; Piro, RM.; Esparza, LA. et al. (Mar 2014). "Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.". Cancer Cell 25 (3): 393-405. doi:10.1016/j.ccr.2014.02.004. PMID 24651015.
- ↑ Gulino A, Arcella A, Giangaspero F (November 2008). "Pathological and molecular heterogeneity of medulloblastoma". Curr Opin Oncol 20 (6): 668–75. doi:10.1097/CCO.0b013e32831369f4. PMID 18841049.
- ↑ Rutkowski S, von Hoff K, Emser A, et al. (November 2010). "Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis". J Clin Oncol 28 (33): 4961–4968. doi:10.1200/JCO.2010.30.2299. PMID 20940197.
- ↑ Rutkowski, S.; Bode, U.; Deinlein, F.; Ottensmeier, H.; Warmuth-Metz, M.; Soerensen, N.; Graf, N.; Emser, A. et al. (Mar 2005). "Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.". N Engl J Med 352 (10): 978-86. doi:10.1056/NEJMoa042176. PMID 15758008.